CDH17 and renal carcinoma: We first investigated total and plasma membrane expression of CDH6 and CDH17, together with α2β1 and αIIbβ3 integrins, in different ovarian and renal cancer cell lines, using the HT29 colorectal cancer cell line as positive control for expression of CDH17 and α2β1 integrin.